• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.

作者信息

Intagliata Nicolas M, Maitland Hillary, Pellitier Shawn, Caldwell Stephen H

机构信息

Division of Gastroenterology and Hepatology, University of Virginia Health System, University of Virginia, Charlottesville, VA.

Division of Hematology and Oncology, University of Virginia Health System, University of Virginia, Charlottesville, VA.

出版信息

Liver Transpl. 2017 Mar;23(3):396-397. doi: 10.1002/lt.24708.

DOI:10.1002/lt.24708
PMID:28026110
Abstract
摘要

相似文献

1
Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.肝硬化患者肝移植中直接口服抗凝剂的逆转：向前迈进的一步。
Liver Transpl. 2017 Mar;23(3):396-397. doi: 10.1002/lt.24708.
2
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis.一名正在接受阿哌沙班治疗门静脉血栓形成的患者接受原位肝移植。
J Clin Anesth. 2019 Sep;56:41-42. doi: 10.1016/j.jclinane.2019.01.020. Epub 2019 Jan 23.
3
Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation.两名门静脉血栓形成患者行原位肝移植时应用依达鲁珠单抗逆转达比加群。
Semin Cardiothorac Vasc Anesth. 2021 Sep;25(3):200-207. doi: 10.1177/1089253220982183. Epub 2021 Jan 4.
4
Living donor liver transplantation using a right anterior section of the liver.使用肝脏右前叶进行活体供肝肝移植。
Liver Transpl. 2017 Aug;23(8):1077-1080. doi: 10.1002/lt.24710.
5
[Liver transplantation for the patients with end stage liver disease and portal vein thrombosis].[终末期肝病合并门静脉血栓形成患者的肝移植]
Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Oct 18;41(5):558-60.
6
Liver transplantation followed by pulmonary resection complicated with end-stage liver cirrhosis: a case report.肝移植后肺切除合并终末期肝硬化：一例报告
Anticancer Res. 2015 Jun;35(6):3411-4.
7
Disseminated intravascular coagulation during liver transplantation unleashed by protamine.肝移植期间由鱼精蛋白引发的弥散性血管内凝血
J Clin Anesth. 2019 Nov;57:117-118. doi: 10.1016/j.jclinane.2019.04.017. Epub 2019 Apr 13.
8
Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.关注艾达司珠单抗及其逆转达比加群抗凝作用的潜力。
Drug Des Devel Ther. 2016 May 18;10:1683-9. doi: 10.2147/DDDT.S94167. eCollection 2016.
9
[Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].[新型口服直接抗凝剂抑制剂在严重出血或紧急外科手术患者中的治疗。新型达比加群解毒剂：依达赛珠单抗在临床实践中的地位]
Orv Hetil. 2016 Mar 20;157(12):443-50. doi: 10.1556/650.2016.30391.
10
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.内脏静脉血栓形成和肝硬化患者使用直接口服抗凝剂的抗栓治疗
Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19.

引用本文的文献

1
From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension.从病理生理学到临床实践：门静脉高压症不断发展的药物治疗、临床并发症及药物遗传学考量
Metabolites. 2025 Jan 23;15(2):72. doi: 10.3390/metabo15020072.
2
Perioperative Myocardial Infarction Following Dabigatran Reversal With Idarucizumab in a Patient Undergoing Orthotopic Liver Transplantation.在一名接受原位肝移植的患者中，使用艾达赛珠单抗逆转达比加群后发生围手术期心肌梗死
Cureus. 2023 Aug 15;15(8):e43531. doi: 10.7759/cureus.43531. eCollection 2023 Aug.
3
Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis.
在肝硬化患者中，治疗剂量的直接口服抗凝剂会使国际标准化比值和终末期肝病模型评分出现具有临床意义的升高。
Res Pract Thromb Haemost. 2023 Jan 14;7(1):100052. doi: 10.1016/j.rpth.2023.100052. eCollection 2023 Jan.
4
Anticoagulation Management in Patients With Atrial Fibrillation and Cirrhosis.心房颤动合并肝硬化患者的抗凝管理
Clin Liver Dis (Hoboken). 2021 May 1;17(4):277-281. doi: 10.1002/cld.1048. eCollection 2021 Apr.
5
Prothrombin Complex Concentrate in Liver Transplant Surgery: Correction of Therapeutic Anticoagulation and the Coagulopathy of End-Stage Liver Disease: Case Series.肝移植手术中凝血酶原复合物浓缩剂：纠正治疗性抗凝及终末期肝病凝血障碍：病例系列
Front Pharmacol. 2020 Sep 8;11:566433. doi: 10.3389/fphar.2020.566433. eCollection 2020.
6
Two Dabigatran Fast Reversals in a 4-month Period - a Case Report.4个月内两次达比加群快速逆转——病例报告
Eur J Case Rep Intern Med. 2019 Dec 4;6(12):001311. doi: 10.12890/2019_001311. eCollection 2019.
7
Elevated International Normalized Ratio: A Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients.国际标准化比值升高：肝硬化患者门静脉血栓形成的一个危险因素。
Gastroenterology Res. 2019 Jun;12(3):135-140. doi: 10.14740/gr1179. Epub 2019 Jun 7.
8
Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.肝硬化患者非肿瘤性门静脉血栓的处理。
Dig Dis Sci. 2019 Mar;64(3):619-626. doi: 10.1007/s10620-018-5427-3.
9
Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management.终末期肝病的高凝状态：流行病学、病因及管理综述
Transplant Direct. 2018 Oct 26;4(11):e403. doi: 10.1097/TXD.0000000000000843. eCollection 2018 Nov.
10
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.肝病相关止血与血栓形成的概念与争议：第七届国际肝病凝血会议论文集
Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30.